{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T01:57:44Z","timestamp":1777341464779,"version":"3.51.4"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T00:00:00Z","timestamp":1569628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["5T32HL076136"],"award-info":[{"award-number":["5T32HL076136"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL137562"],"award-info":[{"award-number":["1R01HL137562"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL130539"],"award-info":[{"award-number":["1R01HL130539"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K24HL113128"],"award-info":[{"award-number":["K24HL113128"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K08HD094638"],"award-info":[{"award-number":["K08HD094638"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Harvard Center for Acquired Immunodeficiency Syndrome (AIDS) Research","award":["P30-AI060354"],"award-info":[{"award-number":["P30-AI060354"]}]},{"name":"International Maternal Pediatric AIDS Clinical Trials Network","award":["UM1AI068632"],"award-info":[{"award-number":["UM1AI068632"]}]},{"name":"Nutrition Obesity Research Center","award":["P30-DK040561"],"award-info":[{"award-number":["P30-DK040561"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,22]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Among persons living with human immunodeficiency virus (PHIV), incident heart failure (HF) rates are increased and outcomes are worse; however, the role of amino-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations among PHIV with HF has not been characterized.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients were derived from a registry of those hospitalized with HF at an academic center in a calender year. We compared the NT-proBNP concentrations and the changes in NT-proBNP levels between PHIV with HF and uninfected controls with HF.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 2578 patients with HF, there were 434 PHIV; 90% were prescribed antiretroviral therapy and 62% were virally suppressed. As compared to controls, PHIV had higher admission (3822 [IQR, 2413\u20137784] pg\/ml vs 5546 [IQR, 3257\u20138792] pg\/ml, respectively; P &amp;lt; .001), higher discharge (1922 [IQR, 1045\u20134652] pg\/ml vs 3372 [IQR, 1553\u20135452] pg\/ml, respectively; P &amp;lt; .001), and lower admission-to-discharge changes in NT-proBNP levels (32 vs 48%, respectively; P = .007). Similar findings were noted after stratifying based on left ventricular ejection fraction (LVEF). In a multivariate analysis, cocaine use, a lower LVEF, a higher NYHA class, a higher viral load (VL), and a lower CD4 count were associated with higher NT-proBNP concentrations. In follow-up, among PHIV, a higher admission NT-proBNP concentration was associated with increased cardiovascular mortality (first tertile, 11.5; second tertile, 20; third tertile, 44%; P &amp;lt; .001). Among PHIV, each doubling of NT-proBNP was associated with a 19% increased risk of death. However, among patients living without HIV, each doubling was associated with a 27% increased risk; this difference was attenuated among PHIV with lower VLs and higher CD4 counts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>PHIV with HF had higher admission and discharge NT-proBNP levels, and less change in NT-proBNP concentrations. Among PHIV, VLs and CD4 counts were associated with NT-proBNP concentrations; in follow-up, higher NT-proBNP levels among PHIV were associated with cardiovascular mortality.<\/jats:p><\/jats:sec>","DOI":"10.1093\/cid\/ciz958","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T11:27:13Z","timestamp":1569497233000},"page":"1306-1315","source":"Crossref","is-referenced-by-count":5,"title":["Amino-terminal Pro-B-Type Natriuretic Peptide Among Patients Living With Both Human Immunodeficiency Virus and Heart Failure"],"prefix":"10.1093","volume":"71","author":[{"given":"Raza M","family":"Alvi","sequence":"first","affiliation":[{"name":"Cardiovascular Imaging Research Center, Department of Radiology and Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markella V","family":"Zanni","sequence":"additional","affiliation":[{"name":"Metabolism Unit, Division of Endocrinology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M","family":"Neilan","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine and Department of Pediatrics, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malek Z O","family":"Hassan","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Department of Radiology and Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor","family":"Tariq","sequence":"additional","affiliation":[{"name":"Yale-New Haven Hospital of Yale University School of Medicine, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Zhang","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Department of Radiology and Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Afshar","sequence":"additional","affiliation":[{"name":"Bronx-Lebanon Hospital Center of Icahn School of Medicine at Mount Sinai, Bronx, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dahlia","family":"Banerji","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Department of Radiology and Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connor P","family":"Mulligan","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Department of Radiology and Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Rokicki","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Department of Radiology and Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magid","family":"Awadalla","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Department of Radiology and Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James L","family":"Januzzi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas G","family":"Neilan","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Department of Radiology and Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,9,28]]},"reference":[{"key":"2020082200573080000_CIT0001","doi-asserted-by":"crossref","first-page":"749","DOI":"10.7326\/L16-0091","article-title":"Update of survival for persons with HIV infection in Denmark","volume":"165","author":"Lohse","year":"2016","journal-title":"Ann Intern Med"},{"key":"2020082200573080000_CIT0002","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/jamacardio.2017.0264","article-title":"Association between HIV infection and the risk of heart failure with reduced ejection fraction and preserved ejection fraction in the antiretroviral therapy era: results from the Veterans Aging Cohort study","volume":"2","author":"Freiberg","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2020082200573080000_CIT0003","first-page":"737","article-title":"Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease","volume":"171","author":"Butt","year":"2011","journal-title":"Arch Intern Med"},{"key":"2020082200573080000_CIT0004","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jacc.2016.11.013","article-title":"HIV infection and heart failure outcomes in women","volume":"69","author":"Janjua","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2020082200573080000_CIT0005","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jchf.2019.04.025","article-title":"The risk for sudden cardiac death among patients living with heart failure and human immunodeficiency virus","volume":"7","author":"Alvi","year":"2019","journal-title":"JACC Heart Fail"},{"key":"2020082200573080000_CIT0006","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1161\/CIRCULATIONAHA.113.004574","article-title":"Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research","volume":"129","author":"Remick","year":"2014","journal-title":"Circulation"},{"key":"2020082200573080000_CIT0007","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jacc.2018.04.083","article-title":"Protease inhibitors and cardiovascular outcomes in patients with HIV and heart failure","volume":"72","author":"Alvi","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2020082200573080000_CIT0008","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/cid\/ciq066","article-title":"High prevalence of echocardiographic abnormalities among HIV-infected persons in the era of highly active antiretroviral therapy","volume":"52","author":"Mondy","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2020082200573080000_CIT0009","doi-asserted-by":"crossref","first-page":"e004091","DOI":"10.1161\/CIRCIMAGING.115.004091","article-title":"Cardiac magnetic resonance reveals signs of subclinical myocardial inflammation in asymptomatic HIV-infected patients","volume":"9","author":"Luetkens","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2020082200573080000_CIT0010","doi-asserted-by":"crossref","first-page":"e009857","DOI":"10.1161\/JAHA.118.009857","article-title":"Incidence, predictors, and outcomes of implantable cardioverter-defibrillator discharge among people living with HIV","volume":"7","author":"Alvi","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2020082200573080000_CIT0011","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2013.10.001","article-title":"Systemic effects of inflammation on health during chronic HIV infection","volume":"39","author":"Deeks","year":"2013","journal-title":"Immunity"},{"key":"2020082200573080000_CIT0012","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ahj.2019.01.002","article-title":"Heart failure and adverse heart failure outcomes among persons living with HIV in a US tertiary medical center","volume":"210","author":"Alvi","year":"2019","journal-title":"Am Heart J"},{"key":"2020082200573080000_CIT0013","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/cid\/ciw615","article-title":"Cardiovascular disease risk prediction in the HIV outpatient study","volume":"63","author":"Thompson-Paul","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020082200573080000_CIT0014","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1468-1293.2006.00362.x","article-title":"The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D study","volume":"7","author":"Law","year":"2006","journal-title":"HIV Med"},{"key":"2020082200573080000_CIT0015","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.jacc.2018.01.021","article-title":"N-Terminal Pro-B-type natriuretic peptide in the emergency department: the ICON-RELOADED study","volume":"71","author":"Januzzi","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2020082200573080000_CIT0016","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.jacc.2016.09.931","article-title":"Prognostic implications of changes in N-terminal pro-B-type natriuretic peptide in patients with heart failure","volume":"68","author":"Zile","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2020082200573080000_CIT0017","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.jacc.2011.03.072","article-title":"Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction","volume":"58","author":"Januzzi","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2020082200573080000_CIT0018","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2020082200573080000_CIT0019","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/QAD.0b013e32834404a1","article-title":"N-Terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients","volume":"25","author":"Duprez","year":"2011","journal-title":"AIDS"},{"key":"2020082200573080000_CIT0020","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1089\/aid.2009.0038","article-title":"Elevated NT-pro-BNP levels are associated with comorbidities among HIV-infected women","volume":"25","author":"Mansoor","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2020082200573080000_CIT0021","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jchf.2015.03.007","article-title":"Novel biomarkers of cardiac stress, cardiovascular dysfunction, and outcomes in HIV-infected individuals","volume":"3","author":"Secemsky","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2020082200573080000_CIT0022","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"2020082200573080000_CIT0023","first-page":"1308","article-title":"HCV coinfection possibly promotes left ventricular dysfunction development: analysis of brain natriuretic peptide serum levels in HCV\/HIV-coinfected and HIV-monoinfected patients","volume":"24","author":"Dabrowska","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2020082200573080000_CIT0024","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12981-015-0058-7","article-title":"Factors related to NT-proBNP levels in HIV patients aged over 40 years","volume":"12","author":"Olalla","year":"2015","journal-title":"AIDS Res Ther"},{"key":"2020082200573080000_CIT0025","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1006\/jmcc.2002.2005","article-title":"Transcriptional activation of the BNP gene by lipopolysaccharide is mediated through GATA elements in neonatal rat cardiac myocytes","volume":"34","author":"Tomaru Ki","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"2020082200573080000_CIT0026","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/QAI.0b013e31825c7f24","article-title":"Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system","volume":"60","author":"Chow","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020082200573080000_CIT0027","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/QAI.0b013e3181f4b752","article-title":"Association of immunologic and virologic factors with myocardial infarction rates in a US healthcare system","volume":"55","author":"Triant","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020082200573080000_CIT0028","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/135965350801300215","article-title":"Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial","volume":"13","author":"Phillips","year":"2008","journal-title":"Antivir Ther"},{"key":"2020082200573080000_CIT0029","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(02)11672-2","article-title":"Protease inhibitors and cardiovascular outcomes in patients with HIV-1","volume":"360","author":"Holmberg","year":"2002","journal-title":"Lancet"},{"key":"2020082200573080000_CIT0030","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/00002030-200311210-00010","article-title":"Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men","volume":"17","author":"Mary-Krause","year":"2003","journal-title":"AIDS"},{"key":"2020082200573080000_CIT0031","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1161\/CIRCULATIONAHA.112.129437","article-title":"Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study","volume":"126","author":"Wang","year":"2012","journal-title":"Circulation"},{"key":"2020082200573080000_CIT0032","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ahj.2004.07.010","article-title":"Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy","volume":"149","author":"Krauser","year":"2005","journal-title":"Am Heart J"},{"key":"2020082200573080000_CIT0033","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jacc.2011.06.043","article-title":"Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention","volume":"58","author":"Bhonsale","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2020082200573080000_CIT0034","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1540-8159.2010.02907.x","article-title":"Effect of substance abuse on defibrillation threshold in patients with implantable cardioverter-defibrillator","volume":"34","author":"Perrine","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"key":"2020082200573080000_CIT0035","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1089\/aid.2015.0345","article-title":"Increased antiretroviral therapy use and virologic suppression in the Bronx in the context of multiple HIV prevention strategies","volume":"32","author":"Hanna","year":"2016","journal-title":"AIDS Res Hum Retroviruses"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciz958\/30967150\/ciz958.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/71\/5\/1306\/33672095\/ciz958.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/71\/5\/1306\/33672095\/ciz958.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:05:57Z","timestamp":1664496357000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/71\/5\/1306\/5629142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,28]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,9,28]]},"published-print":{"date-parts":[[2020,8,22]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciz958","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9,1]]},"published":{"date-parts":[[2019,9,28]]}}}